Inspect vs Enzyme — how do they compare? Inspect trades at Rp10.84 (market cap Rp7,66M, Rp3,14M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 17.5× Inspect's market cap, and Inspect's supply is capped (798,4M / 1B INSP (80%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Inspect for 18 Days and Enzyme for 29 Days on average.
| INSP | MLN | |
|---|---|---|
Market Cap | Rp7,66M | Rp134,13M |
Volume (24h) | Rp3,14M | Rp104,56M |
Circulating Supply | 798,4M / 1B INSP (80%) | 3,3M MLN |
Typical Hold Time | 18 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
INSP token maintains a modest market cap of Rp7.66M with 80% of its 1M max supply in circulation. The token shows limited market activity with an average hold time of 18 days, indicating relatively stable holding patterns among current investors. Recent trading data shows minimal price volatility and low volume, suggesting quiet market conditions without significant technical catalysts or protocol developments driving momentum.
Overall outlook remains neutral with limited near-term catalysts. Key opportunity lies in potential ecosystem growth if development activity increases, while major risks include low liquidity and minimal market interest. Investors should monitor for any protocol updates or exchange listings that could impact token utility and trading volume.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Inspect is a Layer 2 protocol suite for Bittensor, designed to facilitate scalable financial activities on TAO. It supports a coordinated ecosystem of products, including TaoFlow (yield and leverage), Substrike (mining pools), NeuralGate (cross-chain access), and taoUSD (stablecoin liquidity). These products benefit users, agents, and protocols involved in decentralized AI. Inspect connects AI, capital, and community to spur genuine economic activity around TAO.
Read more on INSP →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →